Analyst consensus rating
HealthEquity Analyst Rating: Strong Buy
Direct answer
HealthEquity's consensus rating is Strong Buy.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $119.00.
Forecast evidence checked September 17, 2026.
Get free HealthEquity email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $96.00
- Average price target
- $119.00
- High price target
- $142.00
- Low price target
- $105.00
- Low target gap
- +9.4%
- Target upside
- +24%
- High target gap
- +47.9%
- Target range width
- 38.5%
- Consensus rating
- Strong Buy
- Analysts
- 15
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for HealthEquity?
HealthEquity has a verified Strong Buy consensus. The same dataset has an average price target of $119.00.
How far are HealthEquity's low and high targets from the recorded price?
The low target implies +9.4%, while the high target implies +47.9%.
How many analysts are included in HealthEquity's consensus?
The verified consensus includes 15 analysts.
How is HealthEquity's target upside or downside calculated?
The average target of $119.00 is divided by the recorded price of $96.00, then one is subtracted to produce +24%. This does not guarantee a future return.
When was HealthEquity's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.